soul semaglutide Trial (NEJM 2025): Oral led to a 14% ↓ in major CV events vs placebo in T2DM with ASCVD or CKD — no ↑ in serious AEs. #Semaglutide #CardioDiabetes #updatesinmedicine Oral Semaglutide Reduces Cardiovascular Events

Phase 3 clinical trials into survodutide, a new GLP-1, showed it has the potential to combat NASH, one of the complications of NAFLD, with significant improvements seen in 83.0% of patients

Can GLP-1 fight cancer

Zudem ist eine ausreichende Eiweisszufuhr wichtig, um die Muskelmasse zu erhalten

However, the menstrual cycle is governed by a different set of hormones, mainly estrogen and progesterone, produced by the ovaries

For example, researchers in the Diabetes & Metabolism Journal found a higher rate of intestinal obstruction among GLP-1 users compared with patients taking SGLT-2 inhibitors

L-Carnitine Benefits: The Science Behind Carni Shot 3500mg You have seen L-carnitine in fat burners, pre-workouts, and energy drinks